Genentech USA Inc - Company Profile
Powered by 
All the data and insights you need on Genentech USA Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Genentech USA Inc Strategy Report
- Understand Genentech USA Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Genentech USA Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 08 Jan 2024 | Genentech USA Inc Enters Phase I Clinical Trial Agreement with PPD Inc for migoprotafib (GDCT0493091) | Contract Service Agreement |
Genentech USA Inc
|
PPD Inc |
| 21 Nov 2023 | Genentech Enters into Co-Development Agreement with NVIDIA | Partnership | - |
NVIDIA Corp Genentech USA Inc |
| 14 Nov 2023 | Genentech USA Inc Enters Phase I Clinical Trial Agreement with Sarah Cannon Research Institute LLC for migoprotafib (GDCT0493091) | Contract Service Agreement |
Genentech USA Inc
|
Sarah Cannon Research Institute LLC
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer